PCI Pharma Services is pleased to announce Laura Zurlinden has accepted the role of Director of Business Development – West Coast Commercial Packaging.  She joins PCI with more than two decades of successful industry experience.  Laura will be responsible for developing opportunities and building sales to ensure continued growth and success for PCI in this expanding key market.

 

Laura is an experienced Sales and Business Development professional with over 20 years in the outsourced pharmaceutical services market, including commercial contract packaging, clinical trial services, as well as packaging material supply for the pharmaceutical and medical device industries. Prior to joining PCI, Laura held a number of business development roles in the industry at leading service providers.

 

Commenting on Laura’s appointment, Phil DiGiacomo, PCI’s Senior Vice President of Sales and Marketing, noted: “We are very excited to have Laura join the PCI team. She brings a tremendous amount of experience and knowledge to our organization and will be invaluable as a leader in the West Coast territory.  Laura offers a significant depth of technical knowledge both in clinical development and successful commercialization that will truly benefit our clients as they look to develop life-saving medicines for patients around the world.”

 

Laura said of her new role: “I’m excited to join PCI Pharma Services and apply my experiences to my new position. I value the opportunity to work with clients in the development and commercialization of new medicines. I am looking forward to helping clients create optimal packaging solutions and realize successful commercialization of their innovative new therapies.”

 

Laura is replacing Steve Tooker in her new appointment at PCI, who is assuming the role of EU Vice President of Sales for commercial packaging.  Account Executives Chris Riggio, Southern California, and Tina Leung, Northern California, Pacific NW, will be reporting in to Laura.

 

Laura joins PCI at a time of significant investment in its commercial packaging business. Capacity expansions of its leading packaging equipment include multiple new bottling line installations, as well as significant expansion of its global capacity in industry leading Serialization and Anti-Counterfeiting technologies. PCI has also recently acquired pharmaceutical and healthcare packaging services provider Millmount Healthcare, located in the European Union, adding four Dublin based facilities to its global supply network.